226 related articles for article (PubMed ID: 7579052)
1. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.
Klahr S; Breyer JA; Beck GJ; Dennis VW; Hartman JA; Roth D; Steinman TI; Wang SR; Yamamoto ME
J Am Soc Nephrol; 1995 Jun; 5(12):2037-47. PubMed ID: 7579052
[TBL] [Abstract][Full Text] [Related]
2. Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.
J Am Soc Nephrol; 1996 Apr; 7(4):556-66. PubMed ID: 8724889
[TBL] [Abstract][Full Text] [Related]
3. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study.
Levey AS; Adler S; Caggiula AW; England BK; Greene T; Hunsicker LG; Kusek JW; Rogers NL; Teschan PE
Am J Kidney Dis; 1996 May; 27(5):652-63. PubMed ID: 8629624
[TBL] [Abstract][Full Text] [Related]
4. Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.
J Am Soc Nephrol; 1996 Dec; 7(12):2616-26. PubMed ID: 8989740
[TBL] [Abstract][Full Text] [Related]
5. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study.
J Am Soc Nephrol; 1996 Oct; 7(10):2097-109. PubMed ID: 8915969
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure in early autosomal dominant polycystic kidney disease.
Schrier RW; Abebe KZ; Perrone RD; Torres VE; Braun WE; Steinman TI; Winklhofer FT; Brosnahan G; Czarnecki PG; Hogan MC; Miskulin DC; Rahbari-Oskoui FF; Grantham JJ; Harris PC; Flessner MF; Bae KT; Moore CG; Chapman AB;
N Engl J Med; 2014 Dec; 371(24):2255-66. PubMed ID: 25399733
[TBL] [Abstract][Full Text] [Related]
7. Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease.
Torres VE; Abebe KZ; Schrier RW; Perrone RD; Chapman AB; Yu AS; Braun WE; Steinman TI; Brosnahan G; Hogan MC; Rahbari FF; Grantham JJ; Bae KT; Moore CG; Flessner MF
Kidney Int; 2017 Feb; 91(2):493-500. PubMed ID: 27993381
[TBL] [Abstract][Full Text] [Related]
8. Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease.
Ecder T; Chapman AB; Brosnahan GM; Edelstein CL; Johnson AM; Schrier RW
Am J Kidney Dis; 2000 Mar; 35(3):427-32. PubMed ID: 10692268
[TBL] [Abstract][Full Text] [Related]
9. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease.
Choukroun G; Itakura Y; Albouze G; Christophe JL; Man NK; Grünfeld JP; Jungers P
J Am Soc Nephrol; 1995 Dec; 6(6):1634-42. PubMed ID: 8749691
[TBL] [Abstract][Full Text] [Related]
11. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
Ruggenenti P; Perna A; Mosconi L; Pisoni R; Remuzzi G
Kidney Int; 1998 May; 53(5):1209-16. PubMed ID: 9573535
[TBL] [Abstract][Full Text] [Related]
12. Hypertension and renal injury in experimental polycystic kidney disease.
Kennefick TM; Al-Nimri MA; Oyama TT; Thompson MM; Kelly FJ; Chapman JG; Anderson S
Kidney Int; 1999 Dec; 56(6):2181-90. PubMed ID: 10594794
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
Torres VE; King BF; Chapman AB; Brummer ME; Bae KT; Glockner JF; Arya K; Risk D; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
Clin J Am Soc Nephrol; 2007 Jan; 2(1):112-20. PubMed ID: 17699395
[TBL] [Abstract][Full Text] [Related]
14. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
[TBL] [Abstract][Full Text] [Related]
15. Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?
Brosnahan GM; Abebe KZ; Moore CG; Bae KT; Braun WE; Chapman AB; Flessner MF; Harris PC; Hogan MC; Perrone RD; Rahbari-Oskoui FF; Steinman TI; Torres VE; The Halt Pkd Investigators
Curr Hypertens Rev; 2018; 14(1):39-47. PubMed ID: 29564978
[TBL] [Abstract][Full Text] [Related]
16. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
17. Measured and Estimated Glomerular Filtration Rate to Evaluate Rapid Progression and Changes over Time in Autosomal Polycystic Kidney Disease: Potential Impact on Therapeutic Decision-Making.
Miquel-Rodríguez R; González-Toledo B; Pérez-Gómez MV; Cobo-Caso MÁ; Delgado-Mallén P; Estupiñán S; Cruz-Perera C; Díaz-Martín L; González-Rinne F; González-Delgado A; Torres A; Gaspari F; Hernández-Marrero D; Ortiz A; Porrini E; Luis-Lima S
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732256
[TBL] [Abstract][Full Text] [Related]
18. Differences between women and men with chronic renal disease.
Coggins CH; Breyer Lewis J; Caggiula AW; Castaldo LS; Klahr S; Wang SR
Nephrol Dial Transplant; 1998 Jun; 13(6):1430-7. PubMed ID: 9641172
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group.
Buckalew VM; Berg RL; Wang SR; Porush JG; Rauch S; Schulman G
Am J Kidney Dis; 1996 Dec; 28(6):811-21. PubMed ID: 8957032
[TBL] [Abstract][Full Text] [Related]
20. Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.
Spithoven EM; Meijer E; Boertien WE; Sinkeler SJ; Tent H; de Jong PE; Navis G; Gansevoort RT
Am J Kidney Dis; 2013 Sep; 62(3):531-40. PubMed ID: 23714171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
